Home
News
Create
Screeners
Insights
Gujarat Terce Laboratories
48.
45
+4.95
(+11.38%)
Market Cap
₹15.37 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+11.38%
1M
+7.24%
6M
-10.16%
1Y
-42.87%
5Y
+453.71%
View Company Insights
Latest news about Gujarat Terce Laboratories
Gujarat Terce Laboratories Schedules Board Meeting for February 4, 2026 to Approve Q3FY26 Financial Results
4 days ago
Gujarat Terce Laboratories Limited announced a board meeting on February 4, 2026, to consider and approve unaudited standalone financial results for Q3FY26 and nine months ending December 31, 2025. The company has implemented a trading window closure from January 1-6, 2026, pursuant to its Code of Conduct for Prevention of Insider Trading, with Company Secretary Ashka Solanki digitally signing the official communication to BSE Limited.
Gujarat Terce Labs Converts Warrants, Files SEBI Acquisition Disclosure
Dec 16, 2025
Gujarat Terce Laboratories Reports Record EBITDA Despite Revenue Dip in Q2 FY26
Nov 08, 2025
Gujarat Terce Laboratories Reports Q1 Loss, Reshuffles Board Committees
Aug 11, 2025
Gujarat Terce Laboratories Reports Net Loss Despite Revenue Growth, Settles Tax Disputes
Jul 26, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation